{
  "docId": "019de070-3f4a-73d8-b295-3b15c76ba522",
  "docSlug": "bc1fcb576f82bf5c3541f439604f314c",
  "documentTitle": "Kymera | IPO Presentation Deck | 49 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 41,
  "pageCount": 49,
  "prevPage": 40,
  "nextPage": 42,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Includes a Western blot image showing protein levels under different treatment conditions.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de070-3f4a-73d8-b295-3b15c76ba522/41",
  "deckHref": "/decks/019de070-3f4a-73d8-b295-3b15c76ba522",
  "deckJsonHref": "/decks/019de070-3f4a-73d8-b295-3b15c76ba522.json",
  "deckAnchorHref": "/decks/019de070-3f4a-73d8-b295-3b15c76ba522#slide-41",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.1,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "image",
      "text": "Sidebar navigation showing Cancer/Solid Tumors context.",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "55adf2e3-600a-44b4-aede-b2c2c143a676",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.15,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "STAT3 is activated across a wide range of cancer cells in response to TKI's and chemotherapies, eventually leading to resistance and disease progression. For example, when EGFR mutant (but not WT) NSCLC cell line H1650 was treated with erlotinib, upregulation of p-STAT3 was observed, which was reversed by STAT3 degrader",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a70bbb57-0906-413d-9127-426415014e1c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.5,
        "x": 0.4,
        "y": 0.3
      },
      "kind": "table",
      "text": "Treatment matrix with Erlotinib and STAT3 Degrader, showing p-STAT3, STAT3, and Actin levels via Western blot.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a63abc4-4e5e-4b5d-a79c-6f96fd47eb5e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.15,
        "y": 0.05
      },
      "kind": "title",
      "text": "STAT3 Degradation as Resistant Mechanism in Solid Tumors",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "de350693-da4a-4328-86f2-f2b7e6275a34",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "a383d8fa-f830-476e-9254-4d664a947a52",
      "evidence": "The slide describes a problem (STAT3 degradation as a resistant mechanism in solid tumors) and provides context.",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}